Introduction: To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient's decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients. Methods: In the present study, we conducted a systematic review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients. Results: The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available. Conclusion: Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project / V. Sebri, C. Marzorati, P. Dorangricchia, D. Monzani, R. Grasso, A. Prelaj, L. Provenzano, L. Mazzeo, A.D. Dumitrascu, J. Sonnek, M. Szewczyk, I. Watermann, F. Trovò, N. Dollis, E. Sarris, M.C. Garassino, C.M. Bestvina, A. Pedrocchi, E. Ambrosini, S. Kosta, E. Felip, M. Soleda, A.A. Roca, J. Rodríguez‐morató, A. Nuara, Y. Lourie, M. Fernandez‐pinto, A. Aguaron, G. Pravettoni. - In: CANCER MEDICINE. - ISSN 2045-7634. - 13:9(2024 May), pp. e7159.1-e7159.17. [10.1002/cam4.7159]
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
V. Sebri
Primo
;C. MarzoratiSecondo
;P. Dorangricchia;D. Monzani;R. Grasso;L. Provenzano;L. Mazzeo;A. Nuara;G. PravettoniUltimo
2024
Abstract
Introduction: To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient's decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients. Methods: In the present study, we conducted a systematic review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients. Results: The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available. Conclusion: Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.File | Dimensione | Formato | |
---|---|---|---|
Cancer Medicine - 2024 - Sebri - The impact of decision tools during oncological consultation with lung cancer patients A.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
597.14 kB
Formato
Adobe PDF
|
597.14 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.